Status:
COMPLETED
A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
20+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to demonstrate that Abatacept combined with Methotrexate will demonstrate a dose response efficacy in Japanese subjects with active Rheumatoid Arthritis similar to the dos...
Eligibility Criteria
Inclusion
- patients with active Rheumatoid Arthritis while on methotrexate having 12 tender and 10 swollen joints at randomization
Exclusion
- no current infection or other evolutive or uncontrolled disease
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT00345748
Start Date
June 1 2006
End Date
November 1 2007
Last Update
April 25 2011
Active Locations (38)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Nagoya, Aichi-ken, Japan, 460-0001
2
Local Institution
Nagoya, Aichi-ken, Japan, 466-8550
3
Local Institution
Goshogawara-Shi, Aomori, Japan, 037-0053
4
Local Institution
Chiba, Chiba, Japan